diffuse

Irreversible covalent menin inhibitor, BMF-219, exhibited high potency and complete growth inhibition in high-grade B-cell lymphoma and multiple myeloma (MM) preclinical patient derived ex…

– Plenary Session Presentation on Saturday, November 20 – – Company to Host Conference Call at 8:30 a.m. ET on Monday, November 22 – DURHAM, N.C., Nov. 19, 2021 (GLOBE NEWSWIRE) --…

New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen can improve how long some younger people with a specific form of diffuse large…

COMMUNIQUE DE PRESSE Paris, 06 août 2021, 19h AB Science SA (Euronext - FR0010557264 - AB) diffuse un communiqué de Questions - Réponses faisant suite à son communiqué du 28 juin dernier…